2+ day, 17+ hour ago   (74+ words) Earn more while paying less with flexible yield options and zero hidden fees. Buy, sell, and convert crypto with zero platform fees. Keep more of your profit in your pocket. Watch your rewards compound automatically when you stake 50+ assets with…...

3+ day, 20+ hour ago   (165+ words) Eli Lilly has crushed broader equities in recent years. The company's leadership in the fast-growing GLP-1 market grants it attractive medium-term prospects. The stock can deliver competitive returns over the next five years. LLY Revenue (Annual) data by YCharts The…...

4+ day, 10+ hour ago   (130+ words) Why Did Newmont (NYSE:NEM) Slide Even As Gold Sits Near Record Highs? On September 2, 2026, ELI LILLY & Co executive Eric Dozier transferred 216 shares as a gift at $0 per share. Post-transaction, Dozier maintains ownership of 14,239 shares, reflecting the updated holdings of…...

4+ day, 16+ hour ago   (311+ words) In this article, we will discuss Lilly's position in the neuroscience space and how it is expanding its presence in this area. The relatively small contribution means neuroscience is not yet an important earnings driver for Lilly, but it also…...

5+ day, 5+ hour ago   (922+ words) Obesity is becoming one of healthcare’s biggest long-term challenges, and treating it is creating one of the pharmaceutical industry’s biggest opportunities. For many patients, managing weight goes beyond diet and exercise. Obesity is a chronic disease, and as treatment options…...

5+ day, 7+ hour ago   (280+ words) What's interesting is that Eli Lilly wasn't the first to market with a weight-loss drug in the emerging GLP-1 space. The first company was Novo Nordisk (NYSE: NVO), with Wegovy. But Novo Nordisk struggled to keep up with demand, and…...

5+ day, 14+ hour ago   (798+ words) Eli Lilly LLY and Johnson & Johnson JNJ are two leading U.S.-based healthcare companies with strong positions across the pharmaceutical and biotech industries. Both companies continue to deliver strong revenue and earnings growth and have promising long-term prospects. However, which stock…...

6+ day, 19+ hour ago   (416+ words) Griffin's Citadel Advisors and Druckenmiller's Duquesne Family Office bought Lilly stock in Q2. The billionaires likely capitalized on an opportunity with Lilly's shares tumbling early in the quarter. Lilly continues to generate strong revenue and earnings growth. The adage that "birds…...

1+ week, 3+ day ago   (196+ words) Lilly has acquired some 26 companies since 2023. Sales of its GLP-1 drug are funding the deals. This week, Eli Lilly(NYSE: LLY) announced a deal that will add to its already formidable drug pipeline. The company's leading therapy, MER511, is in Phase…...

1+ week, 3+ day ago   (1069+ words) NEW YORK — Johnson & Johnson shares climbed as much as 2.7% on Wednesday, trading near $278.63 by late morning in New York and extending a yearlong rally that has pushed the healthcare giant into record. The stock was up $7.44 from Tuesday's close of…...